Pulmokine Receives $1 Million To Advance PAH Candidate Into Clinical Trial
Lung Disease News,
Pulmokine recently announced that it has entered into an investment agreement with Broadview Ventures for $1 Million. Resulting…
Pulmokine recently announced that it has entered into an investment agreement with Broadview Ventures for $1 Million. Resulting…
A new study on systemic sclerosis entitled “A comparison of the predictive accuracy of three screening models for pulmonary…